BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1427443)

  • 1. Ultrastructural, immunologic and clinical follow-up of five patients with HCL treated with interferon (IFN) for more than three years.
    Mantovani G; Astara G; Curreli L; Lai P; Turnu E; Locci F; Lantini MS; Cossu M; Riva A; Del Giacco GS
    Haematologica; 1992; 77(4):326-35. PubMed ID: 1427443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
    Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
    Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients.
    Liberati AM; Schippa M; Portuesi MG; Grazia Proietti M; De Angelis V; Ferrajoli A; Cinieri S; Di Clemente F; Palmisano L; Berruto P
    Haematologica; 1991; 76(5):375-82. PubMed ID: 1806440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early response to alpha interferon in a patient affected by hairy cell leukemia.
    Di Raimondo F; Murolo D; Milone G; Cacciola E; Giustolisi R
    Haematologica; 1992; 77(4):355-6. PubMed ID: 1427445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.
    Vedantham S; Gamliel H; Golomb HM
    Cancer Res; 1992 Mar; 52(5):1056-66. PubMed ID: 1737364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-interferon treatment of hairy cell leukemia and associated monoclonal large granular lymphocyte proliferation.
    Sgarabotto D; Zerbinati P; Vianello F; Valeri P; Girolami A; Dazzi F
    Haematologica; 1992; 77(4):367-8. PubMed ID: 1427450
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon-induced surface alterations in hairy cells. A review.
    Gamliel H; Gurfel D; Wu SH; Golomb HM
    Scanning Microsc; 1988 Mar; 2(1):485-92. PubMed ID: 3368772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alpha-IFN on cytokine-induced antigen expression and secretion of TNF, LT and IgM in HCL.
    Hassan IB; Lantz M; Sundström C
    Leuk Res; 1991; 15(10):903-10. PubMed ID: 1921451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin of the soluble interleukin-2 receptor in the serum of patients with hairy cell leukemia.
    Semenzato G; Trentin L; Zambello R; Agostini C; Bulian P; Siviero F; Ambrosetti A; Vinante F; Prior M; Chilosi M
    Leukemia; 1988 Dec; 2(12):788-92. PubMed ID: 3264362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hairy-cell leukemia and alpha-interferon treatment: long-term responders.
    Zinzani PL; Lauria F; Salvucci M; Rondelli D; Raspadori D; Bendandi M; Magagnoli M; Tura S
    Haematologica; 1997; 82(2):152-5. PubMed ID: 9175317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD25-negative hairy cell leukaemia: intracytoplasmic detection of Tac antigen and interferon-induced surface expression.
    Tison T; Dazzi F; Giacon C; Vianello F; Valente ML; Radossi P; Sgarabotto D; Girolami A; Pennelli N; Poletti A
    J Pathol; 1995 Sep; 177(1):41-7. PubMed ID: 7472778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine loop of tumor necrosis factor induced by interferon-alpha in tumor cells from hairy cell leukemia.
    Romquin N; Billard C
    Leukemia; 1995 Jan; 9(1):87-94. PubMed ID: 7845033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
    Federico M; Frassoldati A; Lamparelli T; Foà R; Brugiatelli M; Annino L; Baldini L; Capnist G; Chisesi T; di Celle PF
    Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of interferons in hairy cell leukemia.
    Samuels BL; Rosner MC; Giometti CS; Golomb HM; Brownstein BH
    Leukemia; 1987 Apr; 1(4):365-9. PubMed ID: 2444830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hairy cell leukemia: an ultrastructural study of hairy cells before and after interferon therapy.
    Morroni M; Cinti S
    Tumori; 1995; 81(4):249-55. PubMed ID: 8540121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of interferon-alpha on L-BCGF- and TNF-alpha-induced proliferation of hairy cell leukemia in Japan.
    Tokumine Y; Machii T; Inoue R; Shibayama H; Nishimori Y; Nakamura Y; Nojima J; Tagawa S; Kitani T
    Leukemia; 1995 Jan; 9(1):25-9. PubMed ID: 7845025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia.
    Shehata M; Schwarzmeier JD; Nguyen ST; Hilgarth M; Berger R; Hubmann R; Kickmaier S; Decker T
    Cancer Res; 2000 Oct; 60(19):5420-6. PubMed ID: 11034083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
    Skotnicki AB; Wolska-Smolen T; Blicharski J; Zduńczyk A; Sasiadek U; Pituch-Noworolska A
    Cancer Detect Prev; 1988; 12(1-6):511-22. PubMed ID: 3180143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.